NZ732646A - Complete genome sequence of the methanogen methanobrevibacter ruminantium - Google Patents

Complete genome sequence of the methanogen methanobrevibacter ruminantium

Info

Publication number
NZ732646A
NZ732646A NZ732646A NZ73264610A NZ732646A NZ 732646 A NZ732646 A NZ 732646A NZ 732646 A NZ732646 A NZ 732646A NZ 73264610 A NZ73264610 A NZ 73264610A NZ 732646 A NZ732646 A NZ 732646A
Authority
NZ
New Zealand
Prior art keywords
genome sequence
complete genome
methanobrevibacter ruminantium
methanogen
methanogen methanobrevibacter
Prior art date
Application number
NZ732646A
Inventor
Eric Heinz Altermann
Graeme Trevor Attwood
Gregory Cook
Debjit Dey
Scott A Ferguson
Petrus Hendricus Janssen
William John Kelly
Zhanhao Kong
Suzanne Lambie
Sinead Christine Leahy
Dong Li
Duncan Mcmillan
Sharla Mctavish
Diana Pacheco
Robert Starr Ronimus
Carrie Sang
Carl Yeoman
Original Assignee
Pastoral Greenhouse Gas Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pastoral Greenhouse Gas Res Ltd filed Critical Pastoral Greenhouse Gas Res Ltd
Priority to NZ750559A priority Critical patent/NZ750559A/en
Publication of NZ732646A publication Critical patent/NZ732646A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Disclosed is a group of isolated polypeptides or peptides comprising extracellular domains of amino acid sequences of Methanobrevibacter ruminantium. These isolated polypeptides or peptides are useful in the production of vaccines for treating ruminant animals.
NZ732646A 2009-08-27 2010-08-27 Complete genome sequence of the methanogen methanobrevibacter ruminantium NZ732646A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ750559A NZ750559A (en) 2009-08-27 2010-08-27 Complete genome sequence of the methanogen methanobrevibacter ruminantium

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23729609P 2009-08-27 2009-08-27
NZ57929209 2009-08-27
NZ71441910 2010-08-27

Publications (1)

Publication Number Publication Date
NZ732646A true NZ732646A (en) 2023-01-27

Family

ID=85323532

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ732646A NZ732646A (en) 2009-08-27 2010-08-27 Complete genome sequence of the methanogen methanobrevibacter ruminantium

Country Status (1)

Country Link
NZ (1) NZ732646A (en)

Similar Documents

Publication Publication Date Title
NZ750559A (en) Complete genome sequence of the methanogen methanobrevibacter ruminantium
NZ745324A (en) Vaccines and vaccine components for inhibition of microbial cells
NZ711296A (en) Immunotherapy against several tumors including gastrointestinal and gastric cancer
NZ602943A (en) Modified binding proteins inhibiting the vegf-a receptor interaction
RU2015119517A (en) A NEW METHOD FOR TREATING MYOCARDIAL INFARCTION USING THE HMGB1 FRAGMENT
RU2016146198A (en) THERAPEUTIC DLL4-BINDING PROTEINS
MX2013003681A (en) Engineered nucleic acids and methods of use thereof.
MX2011007467A (en) Modular dna-binding domains and methods of use.
NZ603901A (en) Vectors and sequences for the treatment of diseases
MY156286A (en) Human il-23 antigen binding proteins
ZA201105473B (en) Control of plant stress tolerance,water use efficiency and gene expression using novel aba receptor proteins and synthetic agonists
IN2014DN06164A (en)
NZ604412A (en) Vaccine and methods to reduce campylobacter infection
RU2015119523A (en) A NEW METHOD FOR TREATING SPINAL CORD INJURY USING THE HMGB1 FRAGMENT
NZ603196A (en) Methods of use of soluble cd24 for therapy of rheumatoid arthritis
EA201591593A1 (en) ARTIFICIAL TRANSCRIPTION FACTORS CONSTRUCTED TO PREVENT ENDOSOMES
WO2010144231A3 (en) Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
NZ610620A (en) Inhibitors of apoptosis and uses thereof
NZ609474A (en) Fviii peptides for immune tolerance induction and immunodiagnostics
GB2517354A (en) Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy
IL212078A0 (en) Antibodies to modified human igf-1/e peptides
EP2729157A4 (en) Methods of treatment using a pentapeptide derived from the c-terminus of glucagon-like peptide 1 (glp-1)
MX2010010177A (en) Improved beta thymosin fragments.
NZ732646A (en) Complete genome sequence of the methanogen methanobrevibacter ruminantium
SG10201809464RA (en) Antibody gene expression-secretion system

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 9 YEARS UNTIL 27 AUG 2023 BY SOUTHERN CROSS INTELLECTUAL PROPERTY LIMITED

Effective date: 20230523

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 AUG 2024 BY SOUTHERN CROSS INTELLECTUAL PROPERTY LIMITED

Effective date: 20230724